-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Perspective Therapeutics, Lowers Price Target to $10

Benzinga·04/07/2025 13:58:53
Listen to the news
Truist Securities analyst Nicole Germino maintains Perspective Therapeutics (AMEX:CATX) with a Buy and lowers the price target from $21 to $10.